Optimizing the Temperature for Embryo Culture in In Vitro Fertilization
NCT ID: NCT01506089
Last Updated: 2015-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
55 participants
INTERVENTIONAL
2012-01-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients participating in this study will undergo routine in vitro fertilization (IVF) stimulation. Following egg retrieval, patients with at least 8 mature eggs will have those eggs divided randomly into two groups. Both groups will then under ICSI (intra-cytoplasmic sperm injection) to fertilize the eggs. The groups will randomly be assigned to control or study condition. The control condition group will be cultured at 37 degrees Celsius, the current standard of care. The study group will be cultured at 36 degrees Celsius. All other culture conditions will be kept identical and embryos will be assessed on day 3 and day 5 of development.
On day 5, all well-developed blastocysts will undergo biopsy for Comprehensive Chromosomal Screening (CCS), which will evaluate the chromosomal normalcy of the embryo . Patients will undergo transfer on the morning of day 6 and the highest quality, chromosomally normal embryo from each group (the 36 degree cultured embryos and the 37 degree cultured embryos) will be transferred. If only 1 embryo is available for transfer, the patient will have a single embryo transfer.
All embryos available for cryopreservation will undergo biopsy for CCS before being frozen. Some arrested embryos from each temperature group will also undergo genetic analysis to evaluate chromosomal normalcy or mosaicism.
The female patient will undergo a blood draw at 9 weeks gestation and buccal swabs will be obtained from the infant(s) after birth.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incubator Temperature for Culturing Human Embryos
NCT01706900
Embryo Culture At a Constant Temperature of 36.6°C or 37.1°C
NCT03548532
Evaluation of the Impact of Reduced Oxygen Concentration on Embryonic Development
NCT02919384
Oocyte Cryopreservation: Evaluation of an Oocyte Freezing and Thawing Technique
NCT00713869
Egg Freezing Pilot Study
NCT00839839
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
36 degree group
36 degrees Celsius for the incubators is the experimental condition in this study.
36 degrees Celsius
Embryos in this group will be cultured in incubators set to 36 degrees Celsius.
37 degree group
37 degrees Celsius is the standard incubator temperature for the culture of embryos.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
36 degrees Celsius
Embryos in this group will be cultured in incubators set to 36 degrees Celsius.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female partner between 18 and 41 at onset of IVF cycle
* Normal day 3 FSH (\< or = 12) in RMA NJ laboratory
* Basal antral follicle count of at least 10
* Male partner with greater than 100,000 total motile spermatozoa per ejaculate (donor sperm is ok)
* BMI \< or = 32 kg/m2
Exclusion Criteria
* Use of testicular aspiration or biopsy procedures to obtain sperm
* Unevaluated ovarian mass or diagnosis of surgically-confirmed stage IV endometriosis
* Presence of hydrosalpinges that communicate with the uterine cavity
* History of endometrial insufficiency
* Any contraindication to undergoing IVF or gonadotropin stimulation
* Prior poor fertilization rate- less than 50% of mature eggs
* Prior poor blastulation rate- less than 10% of 2PNs (day 1 embryos)
18 Years
41 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Reproductive Medicine Associates of New Jersey
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard T Scott, MD
Role: PRINCIPAL_INVESTIGATOR
Reproductive Medicine Associates of New Jersey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Reproductive Medicine Associates of New Jersey
Morristown, New Jersey, United States
Reproductive Medicine Associates of Pennsylvannia
Allentown, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hong KH, Lee H, Forman EJ, Upham KM, Scott RT Jr. Examining the temperature of embryo culture in in vitro fertilization: a randomized controlled trial comparing traditional core temperature (37 degrees C) to a more physiologic, cooler temperature (36 degrees C). Fertil Steril. 2014 Sep;102(3):767-73. doi: 10.1016/j.fertnstert.2014.06.009. Epub 2014 Jul 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RMA-2011-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.